Evidence map›Paper›PMID 38589361›Full record

ArticleNature communications2024

Comparative characterization of the infant gut microbiome and their maternal lineage by a multi-omics approach.

Tomás Clive Barker-Tejeda, Elisa Zubeldia-Varela, Andrea Macías-Camero, Lola Alonso, Isabel Adoración Martín-Antoniano, María Fernanda Rey-Stolle, Leticia Mera-Berriatua, Raphaëlle Bazire, Paula Cabrera-Freitag, Meera Shanmuganathan and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Health benefits ofFrontiers in microbiology · 2026
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Tomás Clive Barker-Tejeda *Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0002-2942-5876
Elisa Zubeldia-Varela *Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0002-3030-6313
Andrea Macías-Camero *Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0002-6487-4212
Lola AlonsoGenetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID http://orcid.org/0000-0002-3493-718X
Isabel Adoración Martín-AntonianoDepartamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
María Fernanda Rey-StolleCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0002-0873-4485
Leticia Mera-BerriatuaDepartamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Raphaëlle BazireDepartment of Allergy, Hospital Infantil Niño Jesús, Fib-HNJ, Madrid, Spain.
Paula Cabrera-FreitagPedriatic Allergy Unit, Allergy Service, Hospital General Universitario Gregorio Marañón, and Gregorio Marañón Health Research Institute, Madrid, Spain.ORCID http://orcid.org/0000-0002-6117-6582
Meera ShanmuganathanDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0001-9446-6749
Philip Britz-McKibbinDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0001-9296-3223
Carles UbedaFundació per al Foment de la Investigació Sanitària i Biomèdica de la Comunitat Valenciana (FISABIO), Valencia, Spain.ORCID http://orcid.org/0000-0003-0560-4658
M Pilar FrancinoCIBER en Epidemiología y Salud Pública, Madrid, Spain.ORCID http://orcid.org/0000-0002-4510-5653
Domingo BarberDepartamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0002-5488-5700
María Dolores Ibáñez-SandínDepartment of Allergy, Hospital Infantil Niño Jesús, Fib-HNJ, Madrid, Spain.
Coral BarbasCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.ORCID http://orcid.org/0000-0003-4722-491X
Marina Pérez-GordoDepartamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain. marina.perezgordo@ceu.es.ORCID http://orcid.org/0000-0003-2003-4841
Alma VillaseñorCentro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain. alma.villasenor@ceu.es.ORCID http://orcid.org/0000-0002-6652-2739
Universidad San Pablo CEU · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital Infantil Universitario Niño Jesús · ESMcMaster University · CAHospital General Universitario Gregorio Marañón · ESSpanish National Cancer Research Centre · ES

Funding

Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación) PCI2018-092930Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI17/01087Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI19/00044Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI20/01366
6 · The paper itself

Abstract

The human gut microbiome establishes and matures during infancy, and dysregulation at this stage may lead to pathologies later in life. We conducted a multi-omics study comprising three generations of family members to investigate the early development of the gut microbiota. Fecal samples from 200 individuals, including infants (0-12 months old; 55% females, 45% males) and their respective mothers and grandmothers, were analyzed using two independent metabolomics platforms and metagenomics. For metabolomics, gas chromatography and capillary electrophoresis coupled to mass spectrometry were applied. For metagenomics, both 16S rRNA gene and shotgun sequencing were performed. Here we show that infants greatly vary from their elders in fecal microbiota populations, function, and metabolome. Infants have a less diverse microbiota than adults and present differences in several metabolite classes, such as short- and branched-chain fatty acids, which are associated with shifts in bacterial populations. These findings provide innovative biochemical insights into the shaping of the gut microbiome within the same generational line that could be beneficial in improving childhood health outcomes.

Indexed as

Gastrointestinal MicrobiomeAdultAgedChildFecesFemaleHumansInfantInfant, NewbornMaleMetabolomeMothersMultiomicsRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID38589361
PMCPMC11001937
OpenAlexW4394577198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.